Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
AMREP Corp
AXR
$118M
| $626K | ﹤0.01% |
97,616
+8,136
| +9% | +$53.1K |
|
|
LMRK
2702
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $625K | ﹤0.01% |
41,828
-26,672
| -39% | -$410K |
|
2703
Centrus Energy
LEU
$3.69B
| $623K | ﹤0.01% |
102,900
-3,600
| -3% | -$22.3K |
|
2704
Gyre Therapeutics
GYRE
$706M
| $620K | ﹤0.01% |
8,770
+5,344
| +156% | +$312K |
|
2705
HUTCHMED
HCM
$2.13B
| $618K | ﹤0.01% |
+31,000
| New | +$465K |
|
|
ERS
2706
DELISTED
Empire Resources, Inc.
ERS
| $618K | ﹤0.01% |
89,200
+14,800
| +20% | +$87.1K |
|
2707
Titan Machinery
TITN
$431M
| $614K | ﹤0.01% |
40,000
-41,500
| -51% | -$580K |
|
|
CSOD
2708
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $614K | ﹤0.01% |
+15,800
| New | +$651K |
|
|
HI
2709
DELISTED
Hillenbrand
HI
| $613K | ﹤0.01% |
17,100
-68,700
| -80% | -$2.53M |
|
2710
Buckle
BKE
$2.33B
| $611K | ﹤0.01% |
+32,850
| New | +$662K |
|
|
AAV
2711
DELISTED
Advantage Oil & Gas Ltd
AAV
| $610K | ﹤0.01% |
92,400
-83,400
| -47% | -$525K |
|
2712
Magnite
MGNI
$3.49B
| $607K | ﹤0.01% |
103,100
-72,800
| -41% | -$567K |
|
|
ANCB
2713
DELISTED
Anchor Bancorp
ANCB
| $607K | ﹤0.01% |
23,400
+1,748
| +8% | +$46.1K |
|
|
OCIP
2714
DELISTED
OCI Partners LP
OCIP
| $606K | ﹤0.01% |
60,608
+7,418
| +14% | +$70.7K |
|
2715
ACNB Corp
ACNB
$656M
| $604K | ﹤0.01% |
20,939
+5,639
| +37% | +$168K |
|
|
CLSD
2716
DELISTED
Clearside Biomedical
CLSD
| $604K | ﹤0.01% |
+5,073
| New | +$599K |
|
|
SBCP
2717
DELISTED
Sunshine Bancorp, Inc
SBCP
| $604K | ﹤0.01% |
28,860
+5,460
| +23% | +$102K |
|
|
RDHL
2718
Redhill Biopharma
RDHL
$3.59M
| $595K | ﹤0.01% |
62
+37
| +148% | +$370K |
|
2719
Innoviva
INVA
$1.5B
| $594K | ﹤0.01% |
+42,920
| New | +$505K |
|
|
IHC
2720
DELISTED
Independence Holding Company
IHC
| $593K | ﹤0.01% |
31,900
-14,000
| -31% | -$264K |
|
|
EEI
2721
DELISTED
Ecology and Environment
EEI
| $592K | ﹤0.01% |
59,100
+6,200
| +12% | +$62.8K |
|
|
EMMS
2722
DELISTED
Emmis Communications Corp
EMMS
| $592K | ﹤0.01% |
257,249
+2,767
| +1% | +$7.57K |
|
2723
Federal Signal
FSS
$7.71B
| $591K | ﹤0.01% |
42,800
+17,800
| +71% | +$268K |
|
|
TRT
2724
Trio-Tech International
TRT
$115M
| $590K | ﹤0.01% |
285,000
+13,400
| +5% | +$24.9K |
|
|
WEB
2725
DELISTED
Web.com Group, Inc.
WEB
| $587K | ﹤0.01% |
+30,400
| New | +$599K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.